Sentences with phrase «share growth rate at»

It sports the highest average three - year earnings - per - share growth rate at 77 % and has a modest book value multiple of 0.9.

Not exact matches

Currently, the company is trading at about 25 times earnings and with a long - term earnings per share growth rate of about 15 %, its price - to - earnings to growth ratio — a metric used to value fast growing companies — is about 1.4.
Such risks, uncertainties and other factors include, without limitation: (1) the effect of economic conditions in the industries and markets in which United Technologies and Rockwell Collins operate in the U.S. and globally and any changes therein, including financial market conditions, fluctuations in commodity prices, interest rates and foreign currency exchange rates, levels of end market demand in construction and in both the commercial and defense segments of the aerospace industry, levels of air travel, financial condition of commercial airlines, the impact of weather conditions and natural disasters and the financial condition of our customers and suppliers; (2) challenges in the development, production, delivery, support, performance and realization of the anticipated benefits of advanced technologies and new products and services; (3) the scope, nature, impact or timing of acquisition and divestiture or restructuring activity, including the pending acquisition of Rockwell Collins, including among other things integration of acquired businesses into United Technologies» existing businesses and realization of synergies and opportunities for growth and innovation; (4) future timing and levels of indebtedness, including indebtedness expected to be incurred by United Technologies in connection with the pending Rockwell Collins acquisition, and capital spending and research and development spending, including in connection with the pending Rockwell Collins acquisition; (5) future availability of credit and factors that may affect such availability, including credit market conditions and our capital structure; (6) the timing and scope of future repurchases of United Technologies» common stock, which may be suspended at any time due to various factors, including market conditions and the level of other investing activities and uses of cash, including in connection with the proposed acquisition of Rockwell; (7) delays and disruption in delivery of materials and services from suppliers; (8) company and customer - directed cost reduction efforts and restructuring costs and savings and other consequences thereof; (9) new business and investment opportunities; (10) our ability to realize the intended benefits of organizational changes; (11) the anticipated benefits of diversification and balance of operations across product lines, regions and industries; (12) the outcome of legal proceedings, investigations and other contingencies; (13) pension plan assumptions and future contributions; (14) the impact of the negotiation of collective bargaining agreements and labor disputes; (15) the effect of changes in political conditions in the U.S. and other countries in which United Technologies and Rockwell Collins operate, including the effect of changes in U.S. trade policies or the U.K.'s pending withdrawal from the EU, on general market conditions, global trade policies and currency exchange rates in the near term and beyond; (16) the effect of changes in tax (including U.S. tax reform enacted on December 22, 2017, which is commonly referred to as the Tax Cuts and Jobs Act of 2017), environmental, regulatory (including among other things import / export) and other laws and regulations in the U.S. and other countries in which United Technologies and Rockwell Collins operate; (17) the ability of United Technologies and Rockwell Collins to receive the required regulatory approvals (and the risk that such approvals may result in the imposition of conditions that could adversely affect the combined company or the expected benefits of the merger) and to satisfy the other conditions to the closing of the pending acquisition on a timely basis or at all; (18) the occurrence of events that may give rise to a right of one or both of United Technologies or Rockwell Collins to terminate the merger agreement, including in circumstances that might require Rockwell Collins to pay a termination fee of $ 695 million to United Technologies or $ 50 million of expense reimbursement; (19) negative effects of the announcement or the completion of the merger on the market price of United Technologies» and / or Rockwell Collins» common stock and / or on their respective financial performance; (20) risks related to Rockwell Collins and United Technologies being restricted in their operation of their businesses while the merger agreement is in effect; (21) risks relating to the value of the United Technologies» shares to be issued in connection with the pending Rockwell acquisition, significant merger costs and / or unknown liabilities; (22) risks associated with third party contracts containing consent and / or other provisions that may be triggered by the Rockwell merger agreement; (23) risks associated with merger - related litigation or appraisal proceedings; and (24) the ability of United Technologies and Rockwell Collins, or the combined company, to retain and hire key personnel.
Sanderson thinks that listening hours can expand at a 14 % compound annual growth rate through 2017 and 11 % through 2020, while its share of people who listen to music can grow from 8 % in 2013 to 18 % by 2020.
Oakland - based Revolution Foods (# 2) is growing at a 5 - year compounded annual growth rate of 144 %, and is setting a new standard in the food industry by offering profit sharing to its employees.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Echelon is now focusing its growth on «smart» commercial & municipal LED lighting (although its fab-less chip business has apparently now stabilized after a long decline), and if the lighting business accelerates (and it could, due to recent sales force hires and new products), I think there's a chance it can hit a break - even annualized revenue run - rate of $ 40 million by Q4 - 2019 (pushed back from my earlier hoped - for timeline) at which point — assuming $ 14 million of remaining net cash (vs. an estimated $ 18 million at the end of Q2 2018) and 4.7 million shares outstanding (vs 4.52 million today), an enterprise value of 1x revenue on this 53 % gross margin company would put the stock in the mid - $ 11s per share.
But because the category grew at a faster rate than Kraft's sales growth, the company's share declined slightly, a spokesman said.
The 18.1 % growth expected this year for US display advertising is down somewhat from more robust rates of increase in 2011 and 2012, but eMarketer continues to be bullish on the prospects for digital display advertising — especially at social media properties like Facebook and Twitter, as well as at Google, which has dramatically increased its overall share of the display market in recent years.
FedEx still offers an earnings growth rate that is high for large companies, yet we were able to purchase shares at prices that were first seen in 2003, even though earnings per share have more than doubled over the period.
To screen for «dividend growth» shares that may have lower starting yields but have more potential to grow future payouts at high rates, we simply need to make a few adjustments to our screening parameters.
Under Greenlight's plan, the dividend shares would pay GM's current quarterly dividend at an annual rate of $ 1.52 per share, while the capital appreciation shares would be entitled to the remainder of GM's earnings in excess of current dividends, including all future growth.
Is an increase from 2.6 % of GDP in 1981 to 3.1 % of GDP in 2012 unsustainable?  Yes, I suppose so, if this rate of increase continues for another few centuries. The same argument the CFIB makes for municipal spending could be made for corporate profits but far moreso. After adjusting for inflation, corporate profits have increased by 245 % since 1992, doubling as a share of GDP and growing at a rate of ten times Canadaâ $ ™ s cumulative population growth of just 23 % since 1992.
Let's look at how Kansas City performed in the index's three key metrics: rate of startup growth, share of scaleups and high - growth company density.
Growth Investing — An investing strategy that focuses on stocks that are growing at a higher rate, without regard to price per share.
Woolworths appears to be taking advantage of volume growth from recent market share gains to cut food and grocery prices at a faster rate than arch rival Coles.
China is the third largest producer of these services (17 percent global share) and continues to grow at a far faster rate (19 percent annual growth) than the U.S. and other developed countries.
The strategy for Nissan this year would to attempt to increase market share from the current rate at 1.5 % to 5 % in the Indian passenger car segment, which saw the sale of over 26 lakh cars in the fiscal year 14 - 15, when the segment registered a year - on - year growth of 3.9 %.
On the growth side, we favour firms that have increased their sales - per - share and earnings - per - share at a reasonable rate.
Its average three - year earnings - per - share growth rate comes in at 32.4 % and revenue - per - share growth clocks in at an average of 13.9 % over the same period.
On the growth side, we favour firms that have increased their sales per share and earnings per share at a reasonable rate.
For example, in 1995, we were experiencing 8 % EPS (earnings per share) growth rates, while this year has just been at 2 %.
If the company grows earnings - per - share at its expected 5 % to 8 % a year growth rate, investors will have total returns of between 8 % and 11 % a year from dividends (3 %) and earnings - per - share growth (5 % to 8 %).
To weed out those at risk of cutting their dividend, companies must have a positive five - year dividend - per - share growth rate and a dividend payout ratio of no more than 60 % of earnings.
Practically speaking, however, the minimum benchmark for being classified as a growth stock is at least a 10 % annual growth rate in earnings per share, with many investors requiring a 20 % annual growth rate.
A Score for each value stock is then assigned based on six historical variables: market cap, stock liquidity (i.e., annual trading volume / shares), asset turnover (i.e., assets / revenues), total debt to equity, cash to assets and year - over-year EBIT annual growth rate, one variable at a time.
These stocks were then sorted by the following historical financial metrics (using the most recently reported financials): market cap, annual trading volume to shares outstanding, assets to revenues, total debt to equity, cash to assets and year - over-year EBIT annual growth rate, one financial metric at a time.
It also sports the highest three - year sales - per - share annual growth rate at 16 %.
Delta Air Lines generated the largest three - year earnings - per - share annual growth rate at 87 % while offering a low trailing earnings multiple of 11 and a forward earnings multiple of 10.
Because the shares of First Cash Financial Services were significantly undervalued at the beginning of the timeframe measured, long - term shareholder annual returns of over 30 % have exceeded the company's 20 % earnings growth rate.
Now that Johnson & Johnson is a $ 341 billion company, the dividend growth that continues at a rate of more than double the prevailing inflation rate suggests that the New Brunswick healthcare giant has developed an unusual formula for making you wealthy if you get your name on the ownership of shares and never part with them.
At first, that doesn't sound all that different from Hershey, until you adjust for the fact that the future earnings per share growth rate of Visa is much higher than what you can get from Hershey.
The yield is currently at 4.45 % based on the CAD 0.66 quarterly dividend payout.I have valued the shares using a dividend discount model analysis with a 10 % discount rate and an 7 % long - term growth rate.
Share Repurchases: Let's assume the DCP share price increases by just over 40 % in the next year & continues at half that growth rate (just over 20 % pa) for the following 4 yShare Repurchases: Let's assume the DCP share price increases by just over 40 % in the next year & continues at half that growth rate (just over 20 % pa) for the following 4 yshare price increases by just over 40 % in the next year & continues at half that growth rate (just over 20 % pa) for the following 4 years.
Looking at the historic growth rates for per share dividends, earnings, revenue, and free cash flow gives a better idea of the true operational results that Hershey has delivered.
Just 3 years ago, the quarterly dividend was $ 0.60 / share, which means their dividends have grown by 26 % over 3 years, at a compounded annual growth rate of 8 % a year.
Now, granted: Over the last 5 years, AUME growth been impressive, but the continued decline in fee rates & the virtual absence of performance fees means revenue / earnings were stable at best (averaging # 20 million & 2.4 p per share, respectively).
All value stocks are then ranked based on six historical (and available at the time) criteria: market cap, stock liquidity (i.e., trading volume / shares), asset turnover (i.e., assets / revenues), total debt to equity, cash to assets and year - over-year EBIT annual growth rate, one variable at a time.
Dover is anticipated to increase earnings per share at a rate of 12.10 % over the next five years, so that dividend growth of the past could accelerate in the future.
Growth stocks are equity shares of companies whose earnings are expected to increase at an above - average rate.
The German residential battery storage market has grown rapidly since 2015 but the growth in demand for residential storage solutions grew in other European countries at an even faster rate - so that Germany's share of this market segment in Europe declined from 80 % in 2015 to 60 % in 2017.
In the same year, HDFC ERGO General Insurance maintained 4 % market share and registered growth at a rate of 9.5 %.
Cedar's shares are trading at a discount compared to other shopping center REITs because the firm has had slow internal growth and there are a few troubled properties in Ohio in its portfolio, which has hurt its overall occupancy rates, according to a note by Todd M. Thomas, a REIT analyst with KeyBanc Capital Markets Inc..
a b c d e f g h i j k l m n o p q r s t u v w x y z